For instance, in October 2024, Novo Nordisk made significant strides with Rybelsus, as the company announced its plan to expand the drugs indication to prevent major adverse cardiovascular events (MACE) in patients with Type 2 diabetes, cardiovascular disease (CVD), or chronic kidney disease (CKD)
Weight management The oral form is authorised for long-term weight management, including both weight loss and weight maintenance
These risk factors can include oral health problems such as xerostomia (dry mouth), stained teeth, higher mouth and neck cancer risk, unhealthy food cravings, tooth decay, gum irritation, increased oral bacteria, bad breath, periodontal disease/periodontitis (gum infection), oral lesions (ulcers), leukoplakia (white patches inside your mouth), gingival enlargement/hyperplasia (enlarged gums), candidiasis (fungal infection), alveolar bone loss (loss of bone mass around the teeth), stomatitis (inflamed mouth), and interference with calcium absorption
Participants who followed a maintenance dose protocol with gradual adjustments saw much better results, experiencing an average weight regain of just 14% , compared to significantly higher rates among those who stopped medication abruptly
M.RocksonS
)
